Viewing Study NCT05168904


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2026-04-09 @ 8:37 AM
Study NCT ID: NCT05168904
Status: SUSPENDED
Last Update Posted: 2024-02-08
First Post: 2021-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)
Sponsor: Cyclacel Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndrome(MDS) View
Keywords: